2007
DOI: 10.4088/jcp.v68n0208
|View full text |Cite
|
Sign up to set email alerts
|

Melatonin in Schizophrenic Outpatients With Insomnia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
0
2

Year Published

2008
2008
2016
2016

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 90 publications
(33 citation statements)
references
References 0 publications
1
30
0
2
Order By: Relevance
“…It remains unclear whether these results could be also related, at least partially, to the influence of antipsychotic medications and light exposure. The efficacy of exogenous melatonin in treating insomnia associated with schizophrenia was reported by Suresh Kumar et al [30]. In the double-blind, placebo-controlled study, relative to placebo, melatonin significantly improved the quality and depth of nighttime sleep, reduced the number of nighttime awakenings, and increased the duration of sleep without yielding a morning hangover.…”
Section: Circadian Disturbances and Psychosismentioning
confidence: 90%
“…It remains unclear whether these results could be also related, at least partially, to the influence of antipsychotic medications and light exposure. The efficacy of exogenous melatonin in treating insomnia associated with schizophrenia was reported by Suresh Kumar et al [30]. In the double-blind, placebo-controlled study, relative to placebo, melatonin significantly improved the quality and depth of nighttime sleep, reduced the number of nighttime awakenings, and increased the duration of sleep without yielding a morning hangover.…”
Section: Circadian Disturbances and Psychosismentioning
confidence: 90%
“…Data are also accruing that the therapeutic effects of melatonin are in part due to their anti-inflammatory effects. While further research is required to determine the optimal recommended doses (3-12 mg of melatonin is currently commonly used to promote sleep), psychiatrists can recommend doses of melatonin based on previous and current efficacious studies and then adjust the doses based on the results obtained (Cheung et al, 2006;Pignone et al, 2006;Suresh et al, 2007). Also, the use of melatonin in combination with currently used pharmaceuticals requires additional investigation.…”
Section: Discussionmentioning
confidence: 99%
“…Melatonin is an agent with the capacity of entraining of circadian rhythms (chronobiotic effect) as well as having sleep promoting effects and neuroprotective actions (Reiter and Benitez-King, 2009;Reiter et al, 2005a,b;Srinivasan et al, 2006). These properties have been documented in clinical trials with humans as well as in experimental animals (Paredes et al, 2007;Suresh et al, 2007;Wyatt et al, 2006). Considering these effects, melatonin could be a viable strategy to reduce circadian disruption and improve the sleep of patients with schizophrenia.…”
Section: Reasons To Use Melatonin In Schizophreniamentioning
confidence: 99%
See 1 more Smart Citation
“…Ancak şizofreni hastalarında yapılan çalışmalarda sirkadiyen ritim bozukluğuna ve düşük serum melatonin düzeylerine rastlanmıştır. [117] Özellikle şizofreni hastalarında psikotik atak döneminde ve yoğun antipsikotik kullanılan dönemde uyku sorunları yoğun bir şekilde yaşanmak-tadır. Bu nedenle melatonin kullanımının sirkadiyen ritmi bozmadan ve yan etki oluşturmadan şizofreni hastalarının uyku sorunlarını çözebileceği düşü-nülmektedir.…”
Section: Melatonin Ve Psikiyatrik Hastalıklarunclassified